New insider activity at CVS Health ( (CVS) ) has taken place on May 21, 2026.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Director Larry Robbins has executed a major cash-out from CVS Health, selling 3,372,000 shares of the company’s stock in a transaction valued at $317,445,666. This sizable sale highlights a significant move by an insider and represents a substantial monetization of his stake in CVS Health.
Spark’s Take on CVS Stock
According to Spark, TipRanks’ AI Analyst, CVS is a Neutral.
The score is driven by attractive valuation (low P/E with dividend support) and positive technical momentum (price above major moving averages), reinforced by a guidance raise and strong Q1 execution. The main limiter is financial performance: margins and ROE have compressed materially despite revenue growth, and several earnings-call risks (medical cost trends, segment profit pressure, and regulatory/PBM uncertainty) temper upside.
To see Spark’s full report on CVS stock, click here.
More about CVS Health
YTD Price Performance: 19.54%
Average Trading Volume: 8,289,567
Technical Sentiment Signal: Buy
Current Market Cap: $119B